Stroner P L, Brewster D H, Dewar J A, Eremin O, Gould A, Howard G C, Kaye S B
Information & Statistics Division, National Health Service in Scotland, Edinburgh, UK.
Br J Cancer. 1999 Apr;79(11-12):1641-5. doi: 10.1038/sj.bjc.6690262.
The Scottish Cancer Therapy Network (SCTN) was created against a background of rising concerns about perceived variation in the quality of care available to patients with cancer. SCTN has established itself as a major organization with the necessary recognition and infrastructure to provide leadership, support and impetus in the field of clinical guidelines, clinical audit and clinical trials of cancer therapy in Scotland. Since being formed in 1993, SCTN has been instrumental in the development of three evidence-based, clinical guidelines and in the completion of detailed, national, retrospective audits of the treatment of five major tumour sites. The infrastructure has been used successfully to support and encourage trial participation. Challenges for the future are a re-orientation towards prospective audit, widening the constituency and sense of ownership of SCTN as a resource for practising clinicians, and further increasing recruitment into clinical trials.
苏格兰癌症治疗网络（SCTN）是在人们日益担忧癌症患者可获得的护理质量存在明显差异的背景下成立的。SCTN已成为一个主要机构，拥有必要的认可和基础设施，能够在苏格兰癌症治疗的临床指南、临床审计和临床试验领域发挥领导作用、提供支持并推动相关工作。自1993年成立以来，SCTN在制定三项循证临床指南以及完成对五个主要肿瘤部位治疗情况的详细全国性回顾性审计方面发挥了重要作用。该基础设施已成功用于支持和鼓励参与试验。未来面临的挑战包括转向前瞻性审计、扩大作为执业临床医生资源的SCTN的选民范围和主人翁意识，以及进一步提高临床试验的入组率。
